眼科指南

订阅

MedSci主页 / 所有栏目 / 眼科指南

2017 UK专家共识建议：阿柏西普治疗新生血管性年龄相关性黄斑变性

2017-11-06 国外眼科专家协作组（统称） Clin Ophthalmol. 2017 Nov 6;11:1957-1966.

:阿柏西普新生血管性年龄相关性黄斑变性黄斑变性

新生血管性年龄相关性黄斑变性是一种急性发作的慢性渐进性眼疾病，主要影响中心视力。本文主要针对临床应用阿柏西普治疗提出指导建议。

中文标题：

2017 UK专家共识建议：阿柏西普治疗新生血管性年龄相关性黄斑变性

英文标题：

Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update.

发布机构：

国外眼科专家协作组（统称）

发布日期：

2017-11-06

简要介绍：

新生血管性年龄相关性黄斑变性是一种急性发作的慢性渐进性眼疾病，主要影响中心视力。本文主要针对临床应用阿柏西普治疗提出指导建议。

 

拓展指南：与黄斑变性相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2017 UK专家共识建议：阿柏西普治疗新生血管性年龄相关性黄斑变性)] GetToolGuiderByIdResponse(projectId=1, id=a4e5a1c001532a13, title=2017 UK专家共识建议：阿柏西普治疗新生血管性年龄相关性黄斑变性, enTitle=Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update., guiderFrom=Clin Ophthalmol. 2017 Nov 6;11:1957-1966., authorId=null, author=, summary=新生血管性年龄相关性黄斑变性是一种急性发作的慢性渐进性眼疾病，主要影响中心视力。本文主要针对临床应用阿柏西普治疗提出指导建议。 , cover=, journalId=null, articlesId=null, associationId=959, associationName=国外眼科专家协作组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Mon Nov 06 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>新生血管性年龄相关性黄斑变性是一种急性发作的慢性渐进性眼疾病，主要影响中心视力。本文主要针对临床应用阿柏西普治疗提出指导建议。 </P> <P> </P>拓展指南：<strong>与<font color=red>黄斑变性</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=6036f1c001a89516" title="2017 芬兰国家指南：湿性年龄相关性黄斑变性患者的诊断，治疗以及随访" target=_blank>2017 芬兰国家指南：湿性年龄相关性黄斑变性患者的诊断，治疗以及随访</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=224781c0011059ae" title="2014 EURETINA指南：新生血管性年龄相关性黄斑变性的管理" target=_blank>2014 EURETINA指南：新生血管性年龄相关性黄斑变性的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=8e0201c0010092b9" title="2013 RCO管理指南：年龄相关性黄斑变性" target=_blank>2013 RCO管理指南：年龄相关性黄斑变性</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=d95b71c001003a96" title="维生素矿物质补充剂在年龄相关性黄斑变性防治中的临床应用：专家共识" target=_blank>维生素矿物质补充剂在年龄相关性黄斑变性防治中的临床应用：专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=0238b1c000995e91" title="2013 NICE 阿柏西普注射液治疗湿性年龄相关性黄斑变性（TA 294）" target=_blank>2013 NICE 阿柏西普注射液治疗湿性年龄相关性黄斑变性（TA 294）</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E9%BB%84%E6%96%91%E5%8F%98%E6%80%A7" target=_blank>有关黄斑变性更多指南</a></ul>, tagList=[TagDto(tagId=70530, tagName=:), TagDto(tagId=1427, tagName=阿柏西普), TagDto(tagId=66391, tagName=新生血管性年龄相关性黄斑变性), TagDto(tagId=1788, tagName=黄斑变性)], categoryList=[CategoryDto(categoryId=32, categoryName=眼科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7124, appHits=138, showAppHits=0, pcHits=4979, showPcHits=2953, likes=115, shares=7, comments=3, approvalStatus=1, publishedTime=Sat Dec 16 21:00:56 CST 2017, publishedTimeString=2017-11-06, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Dec 16 21:00:56 CST 2017, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 10:06:28 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 UK专家共识建议：阿柏西普治疗新生血管性年龄相关性黄斑变性)])
2017 UK专家共识建议：阿柏西普治疗新生血管性年龄相关性黄斑变性
下载请点击：
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2099240, encodeId=70d520992406f, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200912/39dc01e1c37446dda0bcd038f6af9623/734e2f02d0c7454db686257557ce8fef.jpg, createdBy=86945417602, createdName=朽木青渠, createdTime=Tue Nov 08 19:52:08 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954837, encodeId=5b3d95483e79, content=已看，还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:41:47 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2022-11-08 朽木青渠

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2099240, encodeId=70d520992406f, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200912/39dc01e1c37446dda0bcd038f6af9623/734e2f02d0c7454db686257557ce8fef.jpg, createdBy=86945417602, createdName=朽木青渠, createdTime=Tue Nov 08 19:52:08 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954837, encodeId=5b3d95483e79, content=已看，还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:41:47 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-04-07 ms6000001015893838

    已看，还可以。

    0

相关指南

2017 国际共识声明：脊髓麻醉下剖宫产手术期间应用血管升压类药物治疗低血压

国外麻醉相关专家组（统称） · 2017-11-01